EcoDrugPlus

Cathepsin S-Like

Ensembl ID : ENSSDUG00000002074
Gene Symbol: LOC111222413
3 Cross references
233 Possible Orthologues:

Cell Division Cycle 7

Ensembl ID : ENSSDUG00000011476
Gene Symbol: CDC7
3 Cross references
207 Possible Orthologues:

Cellular Tumor Antigen P53-Like

Ensembl ID : ENSSDUG00000020390
Gene Symbol: LOC111233015
2 Cross references
232 Possible Orthologues:

Checkpoint Kinase 1

Ensembl ID : ENSSDUG00000004256
Gene Symbol: CHEK1
3 Cross references
177 Possible Orthologues:

Checkpoint Kinase 2

Ensembl ID : ENSSDUG00000018993
Gene Symbol: CHEK2
3 Cross references
205 Possible Orthologues:

Cholecystokinin A Receptor

Ensembl ID : ENSSDUG00000005548
Gene Symbol: CCKAR
4 Cross references
200 Possible Orthologues:

Cholecystokinin B Receptor

Ensembl ID : ENSSDUG00000004846
Gene Symbol: CCKBR
3 Cross references
191 Possible Orthologues:

Cholecystokinin Receptor-Like

Ensembl ID : ENSSDUG00000010358
Gene Symbol: LOC111222731
3 Cross references
193 Possible Orthologues:

Cholesterol 24-Hydroxylase

Ensembl ID : ENSSDUG00000007344
Gene Symbol: LOC111240402
3 Cross references
258 Possible Orthologues:

Cholesteryl Ester Transfer Protein

Ensembl ID : ENSSDUG00000003309
Gene Symbol: CETP
3 Cross references
137 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSSDUG00000018876
Gene Symbol: CHRM2
3 Cross references
195 Possible Orthologues:

Cholinergic Receptor Muscarinic 2

Ensembl ID : ENSSDUG00000016410
Gene Symbol: CHRM2
3 Cross references
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).